| 2025-06-02 |
详情>>
内部人交易：
Cloonan Michael等共交易4笔
|
| 2025-05-31 |
复牌提示：
2025-05-30 19:50:00 停牌，复牌日期 2025-06-03 00:00:01
|
| 2025-05-14 |
详情>>
股本变动：
变动后总股本979.25万股
|
| 2025-05-14 |
详情>>
业绩披露：
2025年一季报每股收益-2.98美元,归母净利润-2906.9万美元,同比去年增长58.36%
|
| 2025-03-27 |
详情>>
业绩披露：
2024年年报每股收益-24.84美元,归母净利润-2.41亿美元,同比去年增长-13.59%
|
| 2024-12-13 |
详情>>
拆分方案：
每20.0000合并分成1.0000股
|
| 2024-11-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-1.1美元,归母净利润-2.12亿美元,同比去年增长-71.8%
|
| 2024-09-27 |
详情>>
业绩披露：
2024年中报每股收益-0.78美元,归母净利润-1.51亿美元,同比去年增长-192.63%
|
| 2024-09-26 |
股东大会：
将于2024-11-06召开股东大会
会议内容 ▼▲
- 1.To elect John O. Agwunobi, Elisabeth Leiderman and Andrew Obenshain as Class II members of the Board of Directors, to serve until the Company’s 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified ("Proposal 1");
2.To approve, on a non-binding, advisory basis, the compensation paid to the Company’s named executive officers ("Proposal 2");
3.To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide for the exculpation of officers for certain breaches of fiduciary duty to the extent permitted by the General Corporation Law of the State of Delaware ("Proposal 3");
4.To approve amendments to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of our common stock at a ratio ranging from any whole number between 1-for-15 and 1-for-20, as determined by our Board of Directors in its discretion ("Proposal 4");
5.To approve an amendment and restatement of the Company's 2023 Incentive Award Plan to, among other things, increase the number of shares of our common stock authorized for issuance thereunder ("Proposal 5");
6.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 ("Proposal 6");
7.To approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal 3, Proposal 4 and/or Proposal 5 ("Proposal 7");
8.To transact any other business that may properly come before the meeting or any adjournment thereof.
|
| 2024-09-13 |
详情>>
业绩披露：
2023年年报每股收益-1.93美元,归母净利润-2.12亿美元,同比去年增长8.00%
|
| 2024-09-13 |
详情>>
业绩披露：
2022年年报每股收益-2.93美元,归母净利润-2.3亿美元,同比去年增长71.89%
|
| 2024-09-13 |
详情>>
业绩披露：
2024年一季报每股收益-0.36美元,归母净利润-6980.4万美元,同比去年增长-428.64%
|
| 2024-08-14 |
财报披露：
美东时间 2024-08-14 盘前发布财报
|
| 2023-11-07 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-1.15美元,归母净利润-1.23亿美元,同比去年增长58.70%
|
| 2023-08-08 |
详情>>
业绩披露：
2023年中报每股收益-0.49美元,归母净利润-5166.8万美元,同比去年增长76.76%
|
| 2023-05-09 |
详情>>
业绩披露：
2023年一季报每股收益0.21美元,归母净利润2124.00万美元,同比去年增长117.39%
|
| 2023-04-28 |
股东大会：
将于2023-06-16召开股东大会
会议内容 ▼▲
- 1.To elect Charlotte Jones-Burton and Mark Vachon as Class I members of the Board of Directors, to serve until the Company’s 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified.
2.To approve, on a non-binding, advisory basis, the compensation paid to the Company’s named executive officers.
3.To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of the Company's common stock.
4.To approve the Company's 2023 Incentive Award Plan.
5.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.
6.To approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal 3 or Proposal 4.
7.To transact any other business that may properly come before the meeting or any adjournment thereof.
|
| 2023-03-29 |
详情>>
业绩披露：
2021年年报每股收益-11.89美元,归母净利润-8.19亿美元,同比去年增长-32.44%
|
| 2022-05-02 |
股东大会：
将于2022-06-22召开股东大会
会议内容 ▼▲
- 1.To elect Nick Leschly and Najoh Tita-Reid as Class III members of the Board of Directors, to serve until the Company’s 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To approve, on a non-binding, advisory basis, the compensation paid to the Company’s named executive officers;
3.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022;
4.To transact any other business that may properly come before the meeting or any adjournment thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-30 |
股东大会：
将于2021-06-15召开股东大会
会议内容 ▼▲
- 1.To elect John O. Agwunobi, M.D., Daniel S. Lynch and William R. Sellers, M.D. as Class II members of the Board of Directors, to serve until the Company’s 2024 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To hold a non-binding advisory vote on the compensation paid to the Company’s named executive officers;
3.To hold a non-binding advisory vote on the frequency of future non-binding advisory votes on the compensation paid to the Company's named executive officers;
4.To approve an amendment to the 2013 Employee Stock Purchase Plan;
5.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021;
6.To transact any other business that may properly come before the meeting or any adjournment thereof.
|
| 2020-06-03 |
股东大会：
将于2020-06-18召开股东大会
会议内容 ▼▲
- 1.To elect Nick Leschly, Douglas A. Melton, Ph.D. and Mark Vachon as Class I members of the Board of Directors, to serve until the Company’s 2023 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To hold a non-binding advisory vote on the compensation paid to the Company’s named executive officers;
3.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2020;
4.To transact any other business that may properly come before the meeting or any adjournment thereof.
|
| 2019-04-23 |
股东大会：
将于2019-06-06召开股东大会
会议内容 ▼▲
- 1.To elect Wendy L. Dixon, Ph.D. and David P. Schenkein, M.D. as Class III members of the Board of Directors, to serve until the Company’s 2022 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To hold a non-binding advisory vote on the compensation paid to the Company’s named executive officers;
3.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019;
4.To transact any other business that may properly come before the meeting or any adjournment thereof.
|
| 2018-04-27 |
股东大会：
将于2018-06-20召开股东大会
会议内容 ▼▲
- 1.To elect John O. Agwunobi, Mary Lynne Hedley, and Daniel S. Lynch as Class II members of the Board of Directors, to serve until the Company’s 2021 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To hold a non-binding advisory vote on the compensation paid to the Company’s named executive officers;
3.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018; 4.To transact any other business that may properly come before the meeting or any adjournment thereof.
|
| 2017-04-21 |
股东大会：
将于2017-06-08召开股东大会
会议内容 ▼▲
- 1.To elect Nick Leschly and Mark Vachon as Class I members of the Board of Directors, to serve until the Company’s 2020 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To hold an advisory vote on the compensation paid to the Company’s named executive officers;
3.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2017;
4.To transact any other business that may properly come before the meeting or any adjournment thereof.
|
| 2016-04-21 |
股东大会：
将于2016-06-02召开股东大会
会议内容 ▼▲
- 1.To elect Wendy Dixon, James Mandell, and David Schenkein as Class III members of the Board of Directors, to serve until the Company’s 2019 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To hold an advisory vote on the compensation paid to the Company’s named executive officers;
3.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2016;
4.To transact any other business that may properly come before the meeting or any adjournment thereof.
|
| 2015-04-24 |
股东大会：
将于2015-06-04召开股东大会
会议内容 ▼▲
- 1.To elect Daniel S. Lynch and John M. Maraganore as Class II members of the Board of Directors, to serve until the Company’s 2018 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To hold an advisory vote on the compensation paid to the Company’s named executive officers;
3.To hold an advisory vote to determine the frequency of future stockholder advisory votes on the compensation paid to the Company’s named executive officers;
4.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2015;
5.To transact any other business that may properly come before the meeting or any adjournment thereof.
|